Takeaway
Neurocognitive assessment of people with primary brain tumors prior to radiotherapy (RT) shows that cognitive deficits such as memory and executive functioning impairment are common especially in those with larger and more aggressive tumors.
Why this matters
Assessing the level of pre-RT neurocognitive impairment in people with brain tumors could help identify those who are at risk of cognitive impairment post-RT and need special support.